Direct myocardial implantation of human fetal stem cells in heart failure patients: Long-term results

Heart Surgery Forum

Volumn 13, Issue 1, 2010, Pages

  Benetti, Federico ^a   Peñaherrera, Ernesto ^b   Maldonado, Teodoro ^b   Vera, Yan Duarte ^b   Subramanian, Valvanur ^c   Geffner, Luis ^a,d,e  

^a Fundacion Benetti   (Argentina)

^b HOSPITAL LUIS VERNAZA   (Ecuador)

^c LENOX HILL HOSPITAL   (United States)

^d Stem Cells Ecuador   (Ecuador)

^e UNIVERSIDAD CATÓLICA DE SANTIAGO DE GUAYAQUIL   (Ecuador)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; FUROSEMIDE; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; EXERCISE TOLERANCE; FEMALE; FETAL STEM CELL; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; MALE; MITRAL VALVE REGURGITATION; OPEN HEART SURGERY; OUTCOME ASSESSMENT; PERICARDIAL EFFUSION; PRIORITY JOURNAL; SAFETY; STEM CELL TRANSPLANTATION; STROKE; SURGICAL TECHNIQUE; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

ADULT; AGED; CARDIAC SURGICAL PROCEDURES; EMBRYONIC STEM CELLS; FEMALE; HEART FAILURE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77449110568     PISSN: 10983511     EISSN: 15226662     Source Type: Journal    
DOI: 10.1532/HSF98.20091130     Document Type: Article

References (21)

1. [ASA/AHA] American Stroke Association, American Heart Association. 2005. Heart disease and stroke statistics - 2005 update. Available at: http://www.americanheart.org/downloadable/heart/1105390918119HD SStats2005Update.pdf. Accessed March 22, 2005.
2. Fujii T, Yau TM, Weisel RD, et al. 2003. Cell transplantation to prevent heart failure: a comparison of cell types. Ann Thorac Surg 76:2062-70.
3. Grischenko VI, Bobirova LE, Dvornek IL, Bobirova VM. 2003. Use of biotechnology in treatment of type 1 diabetes. Transplantology 4:16-9.
4. Hunt SA, Baker DW, Chin MH, et al. 2001. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). Circulation 104:2996-3007.
5. Jones RC, Francis GS, Lauer MS. 2004. Predictors of mortality in patients with heart failure and preserved systolic function in the digitalis investigation group trial. J Am Coll Cardiol 44:1025-9.
6. Kang HJ, Kim HS, Zhang SY, et al. 2004. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 363:751-6.
7. Kocher AA, Schuster MD, Szabolcs MJ, et al. 2001. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7:430-6.
8. O'Donoghue K, Fisk NM. 2004. Fetal stem cells. Best Pract Res Clin Obstet Gynaecol 18:853-75.
9. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, et al. 2001. Bone marrow cells regenerate infarcted myocardium. Nature 410:701-5.
10. Orlic D, Kajstura J, Chimenti S, et al. 2001. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A 98:10344-9.
11. Patel A, Geffner L, Viña RF, et al. 2005. Surgical treatment for congestive heart failure with autologous adult stem cell transplantation. A prospective randomized study. J Thorac Cardiovasc Surg 130:1631-8.
12. Perin EC, Dohmann HF, Borojevic R, et al. 2004. Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation 110(suppl 1):II213-8.
13. Pouly J, Hagège AA, Vilquin JT, et al. 2004. Does the functional efficacy of skeletal myoblast transplantation extend to nonischemic cardiomyopathy? Circulation 110:1626-31.
14. Salogub TV. 2003. Perspective of embryonic cell transplantation when treating patients with epileptiform neuralgia of peripheric genesis. Transplantology 4:184-5.
15. Schächinger V, Assmus B, Britten MB, et al. 2004. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Amer Coll Cardiol 44:1690-9.
16. Taylor DA, Atkins BZ, Hungspreugs P, et al. 1998. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 4:929-33.
17. Tomita S, Mickle DA, Weisel RD, et al. 2002. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg 123:1132-40.
18. Touraine JL. 1999. Induction of transplantation tolerance in humans using stem cell transplants prenatally or postnatally. Transplant Proc 31:2735-7.
19. Tsymbalyuk VI, Yaminsky YY. 2003. Usage of embryonic nerve tissue transplantation to improve the conductivity of spinal cord after traumatic damage in animals and humans. Transplantology 4:199-201.
20. Zhang S, Wang D, Estrov Z, Raj S, Willerson JT, Yeh ET. 2004. Both cell fusion and transdifferentiation account for the transformation of human peripheral blood CD34-positive cells into cardiomyocytes in vivo. Circulation 110:3803-7.
21. Zorin MO, Yurchenko TN, Latyshev DY. 2003. Application of cryopreserved suspension of embryonic neuronal cells in combined treatment of patients with ischemic insults of basal ganglias. Transplantology 4:149-50.